A Study of BBI608 in Combination With Sorafenib, or BBI503 in Combination With Sorafenib in Adult Patients With Hepatocellular Carcinoma

Clinical trial NCT02279719 · COMPLETED

Trial details

NCT number: NCT02279719
Sponsor: Sumitomo Pharma America, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2014-12-01
Primary completion: 2019-07-01
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.